Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The Phase 1 trial in 80 healthy volunteers demonstrated safety and tolerability across four dose levels with no serious adverse events
Minguez, G
[22] [23] Separate NICE technology appraisals cover GLP-1 receptor agonists for weight management in specific patient groups
Your dose may increase over time, but your price remains fixedno hidden dose escalation fees
US$ 29.39
US$ 24.36
US$ 20.34
US$ 29.92
US$ 23.28
